Coronary Artery Disease (CAD)

What is Coronary Artery Disease?

Coronary Artery Disease (CAD) is a condition where the coronary arteries, which supply blood to the heart muscle, become narrowed or blocked due to the buildup of plaque (atherosclerosis). This can reduce blood flow and lead to chest pain (angina) or heart attacks.

Causes and Risk Factors

• Plaque buildup: Due to cholesterol, fatty deposits, and other substances in the artery walls.
• High blood pressure: Can damage arteries over time and promote plaque formation.
• Smoking: Damages the lining of arteries and contributes to plaque buildup.
• Diabetes: Increases the risk of CAD due to high blood sugar levels.
• Family history: A family history of CAD can increase the risk.

Symptoms of Coronary Artery Disease

Common symptoms include:

• Chest pain or discomfort (angina), especially during physical activity or stress
• Shortness of breath
• Fatigue
• Heart attack symptoms: Such as chest pain, nausea, and sweating

Diagnosis and Treatment

Diagnostic Tests

To diagnose CAD, doctors may use:

• Electrocardiogram (ECG): To detect abnormalities in the heart's electrical activity.
• Stress test: To monitor heart function during physical exertion.
• Coronary angiography: An imaging test using dye and X-rays to show artery blockages.
• CT scan: To provide detailed images of the coronary arteries.

Treatment Options

• Lifestyle changes: Diet, exercise, and smoking cessation to improve heart health.
• Medications: Such as statins, beta-blockers, and antiplatelet drugs to manage symptoms and prevent progression.
• Angioplasty and stenting: A minimally invasive procedure to open blocked arteries and place a stent.
• Coronary artery bypass grafting (CABG): Surgery to create a new path for blood to flow around blocked arteries.

Prognosis

The prognosis for coronary artery disease depends on the severity of the blockage, the number of affected arteries, and the effectiveness of treatment. With proper lifestyle changes and medical management, many patients can lead active and fulfilling lives.

References & Research

Historical Background

Coronary artery disease was first described pathologically by Italian anatomist Giovanni Battista Morgagni in 1761. The modern era of treatment began with Andreas Gruentzig performing the first coronary angioplasty in 1977, and Rene Favaloro pioneering coronary artery bypass grafting (CABG) surgery in 1967 at the Cleveland Clinic.

Key Research Papers

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326(4):242-250.
2. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease (COURAGE). N Engl J Med. 2007;356(15):1503-1516.
3. Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease (ISCHEMIA). N Engl J Med. 2020;382(15):1395-1407.
4. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease (SYNTAX). N Engl J Med. 2009;360(10):961-972.
5. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease (4S). Lancet. 1994;344(8934):1383-1389.
6. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE). N Engl J Med. 1996;335(14):1001-1009.
7. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation (CURE). N Engl J Med. 2001;345(7):494-502.
8. Wiviott SD, Braunwald E, Murphy SA, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes (TRITON-TIMI 38). N Engl J Med. 2007;357(20):2001-2015.
9. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes (PLATO). N Engl J Med. 2009;361(11):1045-1057.
10. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease (COMPASS). N Engl J Med. 2017;377(14):1319-1330.
11. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease. Circulation. 2014;130(19):e199-e267.
12. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477.

Back to Table of Contents

Featured Videos

Coronary Artery Disease (CAD) Anatomy, Nursing, Heart Disease, Pathophysiology, Treatment Part 1

Coronary Artery Disease (CAD): Signs, Causes, and Prevention | Mass General Brigham

Coronary Artery Disease (CAD) Treatment Medications Nursing Interventions Heart Disease Part 2

Coronary Artery Disease, Causes, Signs and Symptoms, Diagnosis and Treatment.

What is Coronary Artery Disease? And how do you treat it as a Nurse? (Nursing School Lesson)

Coronary Artery Disease: Prevention, diagnosis and treatment

Coronary Artery Disease: Symptoms, Causes, Treatments | Mass General Brigham

What is coronary artery disease? | Circulatory System and Disease | NCLEX-RN | Khan Academy

Coronary Artery Disease (CAD): Prevention and Condition Management | Mass General Brigham